Quarterly report pursuant to sections 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v2.4.0.8
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenues:        
Product revenues $ 850,027 $ 318,447 $ 1,807,653 $ 831,472
Development service revenues 49,052 163,381 268,114 414,115
Other service revenues 28,378   28,378  
Related party license revenues   650,000 650,000 1,950,000
Total revenues 927,457 1,131,828 2,754,145 3,195,587
Costs and operating expenses:        
Cost of product revenues 365,497 133,371 887,605 391,797
Research and development:        
Research and development costs 725,304 573,562 2,238,574 1,749,253
Reversal of R&D obligation       (882,537)
Selling, general, and administrative 1,697,876 1,441,934 5,034,514 4,585,082
Total costs and operating expenses 2,788,677 2,148,867 8,160,693 5,843,595
Operating loss (1,861,220) (1,017,039) (5,406,548) (2,648,008)
Other income (expense):        
Gain (loss) on change in fair value of deriviative liabilities (1,250,857) (1,667,632) 1,328,112 (1,694,177)
Loss on note payable modification     (1,356,177)  
Other income (expense), net 39,160 2,006 406,548 3,926
Interest income 5,798 7,200 20,688 10,180
Interest expense (127,693) (85,828) (363,115) (2,507,582)
Net loss $ (3,194,812) $ (2,761,293) $ (5,370,492) $ (6,835,661)
Net loss per share attributable to common stockholders:        
Basic and diluted (in Dollars per share) $ (0.05) $ (0.06) $ (0.09) $ (0.18)
Weighted average shares outstanding:        
Basic and diluted (in Shares) 58,254,039 47,531,093 56,845,732 37,807,188